Catalyst OrthoScience Company Profile

Background

Catalyst OrthoScience, founded in 2014 by Dr. Steven Goldberg, is a private medical device company headquartered in Naples, Florida. The company specializes in innovative shoulder arthroplasty solutions, aiming to make orthopedic surgeries less invasive and more efficient for both surgeons and patients. Their mission is to redefine shoulder replacement surgery by developing anatomically correct implants and streamlined surgical techniques that promote faster recovery and improved patient outcomes. Catalyst's vision is to challenge traditional approaches in shoulder arthroplasty, focusing on preserving bone and soft tissue while delivering consistent, reproducible results.

Key Strategic Focus

Catalyst OrthoScience's strategic focus centers on:

• Core Objectives: Developing less invasive surgical solutions that enhance efficiency and patient recovery.

• Areas of Specialization: Shoulder arthroplasty, including anatomic and reverse total shoulder systems.

• Key Technologies Utilized: Ellipsoid head implants, single-tray systems, 3D planning, and patient-specific instrumentation (PSI).

• Primary Markets Targeted: Hospitals and ambulatory surgery centers (ASCs) in the United States.

These strategic focuses aim to address challenges in shoulder replacement procedures by offering solutions that are both innovative and clinically validated.

Financials and Funding

Catalyst OrthoScience has secured a total of $86 million in funding through multiple financing rounds:

• October 2025: Closed a $15 million equity and debt financing round led by RC Capital, with participation from Mutual Capital Partners, Dr. Derace Schaffer, and Western Alliance Bank. This funding is intended to advance the company's commercial and clinical programs.

• October 2021: Completed a $12.3 million oversubscribed Series D financing round led by River Cities Capital and Mutual Capital Partners, supporting the expansion of their product portfolio and market growth.

These investments underscore confidence in Catalyst's innovative approach to shoulder arthroplasty and its potential for growth in the orthopedic market.

Pipeline Development

Catalyst OrthoScience's product pipeline includes:

• Catalyst CSR Total Shoulder System: A stemless, ellipsoid anatomic system designed to preserve bone and soft tissue, promoting faster recovery and improved patient outcomes.

• Archer Reverse Shoulder System: FDA 510(k) cleared, this system offers surgeon-targeted implant positioning and a streamlined, versatile design.

• Archer 3D Planning and Patient-Specific Instrumentation (PSI): A suite of humeral and glenoid guides tailored to the patient's anatomy, enhancing preoperative planning accuracy and intraoperative efficiency.

• Fracture Shoulder System: Designed to improve reverse shoulder arthroplasty for proximal humeral fractures, focusing on tuberosity fixation and healing.

These products are at various stages of development and commercialization, with the company continuing to expand its portfolio to address diverse needs in shoulder arthroplasty.

Technological Platform and Innovation

Catalyst OrthoScience distinguishes itself through:

• Proprietary Technologies: Ellipsoid head implants that mimic the natural shape of the human shoulder, and single-tray systems that simplify surgical procedures.

• Significant Scientific Methods: Utilization of 3D planning and patient-specific instrumentation to enhance surgical precision and patient outcomes.

• AI-Driven Capabilities: While specific AI applications are not detailed, the integration of advanced planning and instrumentation suggests a focus on data-driven surgical solutions.

These innovations aim to improve surgical efficiency, reduce complications, and promote faster recovery for patients.

Leadership Team

The leadership team at Catalyst OrthoScience includes:

• Carl O'Connell: President and CEO, with a background in leading medical device companies and a focus on strategic growth and innovation.

• Steven S. Goldberg, M.D.: Founder and Chief Medical Officer, a board-certified orthopedic surgeon specializing in shoulder procedures, responsible for product development and clinical strategy.

• Dale Davison: Senior Vice President of Manufacturing and Product Development, overseeing the production and development of medical devices.

• Bob Jacobs: Vice President of Sales, leading sales strategies and partnerships.

• Joseph Condon: Chief Operating Officer, managing daily operations and ensuring organizational efficiency.

This team combines expertise in orthopedic surgery, medical device development, and business operations to drive the company's mission forward.

Leadership Changes

As of the latest available information, there have been no significant recent changes or appointments within Catalyst OrthoScience's leadership team.

Competitor Profile

Market Insights and Dynamics

The shoulder arthroplasty market is experiencing significant growth, driven by an aging population and increasing prevalence of shoulder-related conditions. Innovations that offer less invasive procedures, faster recovery times, and improved patient outcomes are in high demand.

Competitor Analysis

Catalyst OrthoScience's key competitors include:

• Acumed: Specializes in orthopedic implants and instruments, with a focus on upper extremity solutions.

• Exactech: Offers a range of orthopedic implants and instruments, including shoulder systems, with a global presence.

• Arthrex: A leading company in orthopedic surgical instruments and implants, known for its comprehensive shoulder arthroplasty solutions.

These competitors have established market positions and offer a variety of shoulder arthroplasty products.

Strategic Collaborations and Partnerships

Catalyst OrthoScience has engaged in strategic collaborations to enhance its product offerings:

• 3D-Side: Partnered for the development of patient-specific instrumentation, integrating 3D planning and PSI into their surgical solutions.

These partnerships aim to integrate advanced technologies into Catalyst's products, enhancing surgical precision and patient outcomes.

Operational Insights

Catalyst OrthoScience differentiates itself through:

• Innovative Product Design: Focus on anatomically correct implants and streamlined surgical techniques.

• Simplified Surgical Workflow: Single-tray systems and patient-specific instrumentation to reduce procedural complexity.

• Clinical Validation: Commitment to evidence-based design and clinically validated outcomes.

These factors contribute to the company's competitive advantage in the orthopedic device market.

Strategic Opportunities and Future Directions

Catalyst OrthoScience is well-positioned to:

• Expand Market Reach: Increase adoption of its products in hospitals and ASCs across the U.S.

• Enhance Product Portfolio: Develop additional solutions addressing various shoulder conditions and surgical needs.

• Leverage Technological Advancements: Integrate emerging technologies to further improve surgical outcomes and operational efficiency.

These strategies align with the company's mission to redefine shoulder replacement surgery through innovation and clinical excellence.

Contact Information

For more information, visit Catalyst OrthoScience's official website.

• Website: catalystortho.com

• LinkedIn: Catalyst OrthoScience LinkedIn